Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2015 1
2016 3
2017 3
2018 3
2019 6
2020 3
2021 5
2022 7
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis.
Zhang Y, Donaher JL, Das S, Li X, Reinhardt F, Krall JA, Lambert AW, Thiru P, Keys HR, Khan M, Hofree M, Wilson MM, Yedier-Bayram O, Lack NA, Onder TT, Bagci-Onder T, Tyler M, Tirosh I, Regev A, Lees JA, Weinberg RA. Zhang Y, et al. Among authors: bagci onder t. Nat Cell Biol. 2022 Apr;24(4):554-564. doi: 10.1038/s41556-022-00877-0. Epub 2022 Apr 11. Nat Cell Biol. 2022. PMID: 35411083 Free PMC article.
Glioma-on-a-Chip Models.
Ustun M, Rahmani Dabbagh S, Ilci IS, Bagci-Onder T, Tasoglu S. Ustun M, et al. Among authors: bagci onder t. Micromachines (Basel). 2021 Apr 26;12(5):490. doi: 10.3390/mi12050490. Micromachines (Basel). 2021. PMID: 33926127 Free PMC article.
Editorial: Cell Death and Targeted Cancer Therapies.
Bagci-Onder T, Kutuk O, Chonghaile TN, Knippschild U. Bagci-Onder T, et al. Front Cell Dev Biol. 2022 Jul 6;10:967720. doi: 10.3389/fcell.2022.967720. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35874828 Free PMC article. No abstract available.
Epigenetic Deregulation of Apoptosis in Cancers.
Ozyerli-Goknar E, Bagci-Onder T. Ozyerli-Goknar E, et al. Among authors: bagci onder t. Cancers (Basel). 2021 Jun 27;13(13):3210. doi: 10.3390/cancers13133210. Cancers (Basel). 2021. PMID: 34199020 Free PMC article. Review.
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.
Yedier-Bayram O, Gokbayrak B, Kayabolen A, Aksu AC, Cavga AD, Cingöz A, Kala EY, Karabiyik G, Günsay R, Esin B, Morova T, Uyulur F, Syed H, Philpott M, Cribbs AP, Kung SHY, Lack NA, Onder TT, Bagci-Onder T. Yedier-Bayram O, et al. Among authors: bagci onder t. Cell Death Dis. 2022 Aug 16;13(8):710. doi: 10.1038/s41419-022-05146-4. Cell Death Dis. 2022. PMID: 35973998 Free PMC article.
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar E, Kala EY, Aksu AC, Bulut I, Cingöz A, Nizamuddin S, Biniossek M, Seker-Polat F, Morova T, Aztekin C, Kung SHY, Syed H, Tuncbag N, Gönen M, Philpott M, Cribbs AP, Acilan C, Lack NA, Onder TT, Timmers HTM, Bagci-Onder T. Ozyerli-Goknar E, et al. Among authors: bagci onder t. Cell Commun Signal. 2023 Nov 16;21(1):328. doi: 10.1186/s12964-023-01335-6. Cell Commun Signal. 2023. PMID: 37974198 Free PMC article.
35 results